Corpus Intelligence IC Memo — MUNSON HEALTHCARE MANISTEE HOSPITAL 2026-04-26 17:22 UTC
IC Memo — MUNSON HEALTHCARE MANISTEE HOSPITAL
Investment Committee Memorandum | MI | 45 beds | Grade C | EBITDA uplift $4.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MUNSON HEALTHCARE MANISTEE HOSPITAL

CCN 230303 | MANISTEE, MI | 45 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MUNSON HEALTHCARE MANISTEE HOSPITAL is a 45-bed rural/critical access in MANISTEE, MI with $54.5M in net patient revenue and a -8.1% operating margin. The hospital serves a payer mix of 38.6% Medicare, 1.3% Medicaid, and 60.1% commercial.

Thesis: Turnaround. Our ML models identify $4.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.1% to -0.7% (+736bps).

Net Revenue HCRIS$54.5M
Current EBITDA COMPUTED$-4.4M
Operating Margin COMPUTED-8.1%
Occupancy HCRIS15.1%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS33.1%
Distress Probability ML56.1%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
73
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -8.1% places it below the state median. Among 73 size-comparable peers (22-90 beds), the median margin is -3.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-90), prioritizing same-state peers. 73 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MUNSON HEALTHCARE MANISTEE HOS (Target)MI45$54.5M-8.1%
TRINITY HEALTH LIVINGSTONMI42$200.4M15.2%
CHELSEA HOSPITALMI79$187.8M-1.1%
OAKLAWN HOSPITALMI78$156.6M-12.4%
MYMICHIGAN MEDICAL CENTER ALMAMI49$142.2M-5.9%
SPECTRUM HEALTH UNITED MEMORIAMI45$129.4M9.7%
DICKINSON COUNTY HEALTHCARE SYMI49$126.3M-4.7%
PROMEDICA HICKMAN HOSPITALMI58$124.7M5.5%
MUNSON HEALTHCARE CADILLAC HOSMI49$122.7M1.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.1M+210bp18mo
Cost to Collect4.5%2.5%$1.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$663K+122bp9mo
Clean Claim Rate88.0%96.0%$35K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.1M
Cost to Collect
$1.1M
Denial Rate Reduction
$1.1M
A/R Days Reduction
$663K
Clean Claim Rate
$35K
Total EBITDA Uplift$4.0M
Current EBITDA$-4.4M
+ RCM Uplift+$4.0M
Pro Forma EBITDA$-403K
Current Margin-8.1%
Pro Forma Margin-0.7%
WC Released (1x)$2.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-6.8M$11.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-6.8M$9.9M0.00x-100.0%
Bull Case9.0x11.0x$-6.1M$20.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.1M$21.0M0.00x-100.0%
Bear Case11.0x10.0x$-7.5M$-6.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-7.5M$-10.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 15.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 56.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 73 hospitals with 22-90 beds
  • Same-state prioritization (n=74)
  • Comp margins: P25=-12.4% / P50=-3.3% / P75=7.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.